Literature DB >> 12034672

Sudden death in a patient without heart failure after a single infusion of 200 mg infliximab: does TNF-alpha have protective effects on the failing heart, or does infliximab have direct harmful cardiovascular effects?

Franco de' Clari, I Salani, E Safwan, A Giannacco.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12034672     DOI: 10.1161/01.cir.0000017216.41471.df

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  9 in total

Review 1.  Anti-tumour necrosis factor alpha therapy in rheumatoid arthritis: an update on safety.

Authors:  K L Hyrich; A J Silman; K D Watson; D P M Symmons
Journal:  Ann Rheum Dis       Date:  2004-07-08       Impact factor: 19.103

2.  The incidence of new onset congestive heart failure and heart failure exacerbation in Veteran's Affairs patients receiving tumor necrosis factor alpha antagonists.

Authors:  Jennifer Cole; Anthony Busti; Salahuddin Kazi
Journal:  Rheumatol Int       Date:  2006-10-07       Impact factor: 2.631

Review 3.  Update of TNF-alpha antagonists and cardiovascular disease in rheumatoid arthritis.

Authors:  Inmaculada del Rincón; Agustín Escalante
Journal:  Curr Rheumatol Rep       Date:  2005-10       Impact factor: 4.592

Review 4.  Biologic drugs and arrhythmic risk in chronic inflammatory arthritis: the good and the bad.

Authors:  Pietro Enea Lazzerini; Pier Leopoldo Capecchi; Mauro Galeazzi; Franco Laghi-Pasini
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

Review 5.  Atherosclerotic cardiovascular disease in rheumatoid arthritis.

Authors:  Inmaculada del Rincón; Agustín Escalante
Journal:  Curr Rheumatol Rep       Date:  2003-08       Impact factor: 4.592

Review 6.  Sudden cardiac death in patients with rheumatoid arthritis.

Authors:  Sherry Masoud; Phang Boon Lim; George D Kitas; Vasileios Panoulas
Journal:  World J Cardiol       Date:  2017-07-26

7.  Intensified immunosuppressive therapy in patients with immune checkpoint inhibitor-induced myocarditis.

Authors:  Jennifer Cautela; Sarah Zeriouh; Melanie Gaubert; Laurent Bonello; Marc Laine; Michael Peyrol; Franck Paganelli; Nathalie Lalevee; Fabrice Barlesi; Franck Thuny
Journal:  J Immunother Cancer       Date:  2020-12       Impact factor: 13.751

8.  Dilated Cardiomyopathy in Pediatric Crohn's Patient: Is It a Manifestation or Consequence of Therapy?

Authors:  Fadi Busaleh; Hussain Albaqshi; Salsabeel AlSultan; Sarah Alateeq; Latifah A Alhashim; Zakariya Aldandan; Nawal Alfarhan
Journal:  Cureus       Date:  2021-11-08

Review 9.  Side effects of TNF-α blockers in patients with psoriatic arthritis: evidences from literature studies.

Authors:  Rosario Peluso; Giovanni Cafaro; Alessandro Di Minno; Salvatore Iervolino; Pasquale Ambrosino; Gelsy Lupoli; Matteo Nicola Dario Di Minno
Journal:  Clin Rheumatol       Date:  2013-04-16       Impact factor: 3.650

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.